NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

OriGene is acquiring substantially all of SDIX's assets and will offer employment to a "substantial majority" of SDIX's employees, SDIX said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.